表紙
市場調查報告書

臨床試驗管理系統(CTMS)的全球市場:各傳送模式,零組件,終端用戶,系統,及地理的成長率,趨勢及預測(2018年∼2023年)

Clinical Trial Management Systems Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 660994
出版日期 內容資訊 英文 118 Pages
商品交期: 2-3個工作天內
價格
臨床試驗管理系統(CTMS)的全球市場:各傳送模式,零組件,終端用戶,系統,及地理的成長率,趨勢及預測(2018年∼2023年) Clinical Trial Management Systems Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年02月01日內容資訊: 英文 118 Pages
簡介

全球臨床試驗管理系統(CTMS)市場,預計從2018年到2023年的預測期間內,以12.5%的年複合成長率成長。臨床試驗管理系統,主要是製藥公司和生物科技企業實施的醫療研究中為了管理大量的臨床資料的軟體解決方案。由於有利的政府政策與各種政府的財政援助機關的支援,預計北美在預測期間內主導市場。

本報告提供全球臨床試驗管理系統市場調查,整體市場趨勢,各產品、地區的詳細趨勢,市場成長的影響要素分析,競爭情形,主要企業簡介等,總括性彙整。

目錄

第1章 簡介

  • 市場定義

第2章 調查方法

第3章 摘要整理

第4章 主要推論

第5章 市場概要

  • 目前市場方案
  • 波特的五力分析
    • 供應商談判力
    • 消費者談判力
    • 新加入廠商的威脅
    • 替代產品及服務的威脅
    • 產業內的競爭

第6章 成長要素,阻礙因素,機會,課題分析(DROC)

  • 成長要素
    • 慢性疾病和文明病的發生率的上升
    • 臨床試驗的外包的增加與受託研究機構(CRO)的實施
    • 醫院資訊系統(HIS)和CTMS的協調
  • 阻礙因素
    • 資料安全的問題
    • CTMS相關的高成本
    • 為了處理CTMS的有資格的技術純熟勞工的不足
  • 市場機會
  • 主要課題

第7章 市場區隔

  • 各傳送模式
    • Web為基礎
    • 內部部署
    • 雲端基礎
  • 各零件
    • 軟體
    • 硬體設備
    • 服務
  • 終端用戶
    • 醫藥品
    • 臨床研究機關
    • 醫療保健供應商
  • 系統的各類型
    • 網站為基礎的臨床試驗管理系統
    • 接受授權的企業為基礎的臨床試驗管理系統
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第8章 競爭情形

  • M&A分析
  • 協定,合作,夥伴關係
  • 新產品的銷售

第9章 主要業者

  • Bioclinica
  • Bio-Optronics, Inc.
  • DATATRAK International, Inc.
  • ERT Clinical
  • IBM Watson Health
  • Medidata Solutions, Inc.
  • MedNet Solutions, Inc.
  • Oracle Corporation
  • Parexel International Corporation
  • Sparta Systems, Inc. 等

第10章 市場未來展望

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 49652

Market Overview

The clinical trial management systems market was valued at USD 665.90 million in 2017. Although the market has been in its nascent stage for the last five years, it has currently established itself as a mature market in the North American region. Asia-Pacific is still experiencing a high growth rate, when compared to other regions. This is mainly attributed to increasing clinical trials due to the high availability of inexpensive resources and increasing population pool in these regions. Moreover, the increased adoption of clinical trial management systems in the past few years has been a major factor that is contributing to the growth of this market.

Europe is expected to register a CAGR of 14.12%, as many Europeans regions are still in the process of adopting these systems. Many companies that have developed clinical trial management systems have found a way to integrate with the existing software providers, in order to provide an efficient workflow in clinical trial management.

The increasing innovative technological advancements to curb the increasing costs associated with clinical trials has resulted in the development of the clinical trials management system. Although these systems have not been completely adapted due to various factors, the increasing awareness and the need to cut down additional costs associated with clinical trials are expected to drive the market in the coming years. Increasing R&D and the rise in the number of clinical trials in the Asian region are expected to further contribute to the growth of the market studied, during the forecast period.

Scope of the Report

The clinical trial management systems market (henceforth, referred to as 'market studied') is segmented on the basis of delivery mode, components, end user, and type of system. Based on delivery, the market is sub-segmented into web-based clinical trial management system, on-premise clinical trial management system, and cloud-based clinical trial management system. By component, the market is sub-segmented into software, hardware, and services. By end user, the market is sub-segmented into pharmaceuticals, contract research organizations, and other end users. Based on the type, the market is sub-segmented into site-based clinical trial management system and licensed enterprise-based clinical trial management system.

Key Market Trends

Cloud-based Clinical Trial Management Systems sub-segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period

Most big pharma and biotech companies are now increasingly adopting the cloud-based CTMS (clinical trial management systems). This increased adoption of cloud-based CTMS is because companies do not require to bear huge costs associated with the purchase of servers, and installation and validation of applications, and their maintenance. The new and advanced cloud-based CTMS facilitate the collaboration among the different groups at various sites to coordinate the successful completion of a trial.

BSI (Business Systems Integration AG) provides CTMS solution as a cloud or on-premise solution. Its functionality enhances the clinical trial operations from initial planning, implementation, reporting, patient monitoring, and entire documentation. Though data security is a typical challenge for cloud CTMS solution, most third-party providers have most advanced datacenters that require the users accessing the CTMS from outside company's firewall to go through the authentication process. All the above factors are expected to contribute to sub-segment's growth over the forecast period.

North America Captured the Largest Market Share and is Expected to Retain its Dominance

North America dominated the overall clinical trial management systems market, with the United States emerging as the major contributor to the market. Factors, such as increasing R&D investments and rise in the demand for drug development, are aiding the growth of the market studied in the country. R&D budgets of the pharmaceutical companies have also increased in the last few years, owing to the increasing focus on regulating markets, complex molecules, and therapy segments. In the United States, pharmaceutical companies spend more money, time, and energy on R&D than others. According to ClinicalTrials.gov, in 2017, 262,433 clinical trials were carried out worldwide, which increased to 285,679 trials in 2018. Whereas, in the United States, 115,123 studies were carried out. Thus, the rise in clinical trials in the region is expected to increase the demand for clinical trial management systems, which, in turn, is expected to aid the growth of the market studied in the United States, over the forecast period.

Competitive Landscape

The presence of major market players, such as Bio-Optronics Inc., MedNet Solutions Inc., Oracle, Parexel International Corporation, and IBM, is, in turn, increasing the overall competitive rivalry of the market. Large organizations rely heavily on advertising expenses and branding strategies, collaborations, initiatives or programs at national levels, which promote their product, and thus, get recognized earlier than other brands in the market. With the high prevalence rate of diseases, the intensity of competitive rivalry in the market is increasing over time.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidences of Chronic Diseases and Lifestyle-related Disorders
    • 4.2.2 Rise in Outsourcing of Clinical Trials and Implementation by Contract Research Organizations
    • 4.2.3 Synchronization of Hospital Information System (HIS) with CTMS
  • 4.3 Market Restraints
    • 4.3.1 Data Security Issues
    • 4.3.2 High Cost Associated with CTMS
    • 4.3.3 Lack of Qualified and Skilled Labor to Handle CTMS
  • 4.4 Industry Attractiveness- Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Delivery Mode
    • 5.1.1 Web-based Clinical Trial Management System
    • 5.1.2 On-premise Clinical Trial Management System
    • 5.1.3 Cloud-based Clinical Trial Management System
  • 5.2 By Component
    • 5.2.1 Software
    • 5.2.2 Hardware
    • 5.2.3 Services
  • 5.3 By End User
    • 5.3.1 Pharmaceuticals
    • 5.3.2 Clinical Research Organization
    • 5.3.3 Other End Users
  • 5.4 By Type of System
    • 5.4.1 Site-based Clinical Trial Management System
    • 5.4.2 Licensed Enterprise-based Clinical Trial Management System
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 United Kingdom
      • 5.5.2.2 Germany
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East & Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East & Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Bioclinica
    • 6.1.2 Bio-Optronics Inc.
    • 6.1.3 DATATRAK International Inc.
    • 6.1.4 ERT Clinical
    • 6.1.5 IBM
    • 6.1.6 Medidata Solutions Inc.
    • 6.1.7 MedNet Solutions Inc.
    • 6.1.8 Oracle
    • 6.1.9 Parexel International Corporation
    • 6.1.10 ArisGlobal

7 MARKET OPPORTUNITIES AND FUTURE TRENDS